Skip to content

← All stories

Markets

An2 therapeutics director Robin Readnour sells $97,322 in shares

1 source ·1 article ·12h ago AN2 Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com Canada ·12h ago

An2 therapeutics director Robin Readnour sells $97,322 in shares